Jun Kikuchi

Lecturer

Keio University School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jun Kikuchi is a Lecturer at Keio University School of Medicine in Japan. His research focuses on autoimmune diseases, particularly systemic lupus erythematosus and rheumatoid arthritis, as reflected in his recent publications. He has contributed to understanding the implications of COVID-19 on patients with autoimmune conditions and has identified potential biomarkers for disease activity. His work emphasizes the clinicopathological aspects and clinical management of complex rheumatologic diseases.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Yuko Kaneko

Keio University School of Medicine

JAPAN

View details

Kathryn A. Gibson

AUSTRALIA

View details

Fumio Hirano

Clinical Associate Professor

Tokyo Medical and Dental University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jun Kikuchi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Anti‐RuvBL1/2 Antibodies in Scleromyositis: A Clinicopathological Report of Two Cases

Clinical Images: Propylthiouracil‐induced antineutrophil cytoplasmic antibody–associated vasculitis with aortic wall thickening

Risk of disease flares after SARS-CoV-2 mRNA vaccination in patients with systemic lupus erythematosus

Cytotoxic Tph subset with low B-cell helper functions and its involvement in systemic lupus erythematosus

Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus

Development of Rheumatoid Arthritis in Cavitary Mycobacterium avium Pulmonary Disease: A Case Report of Successful Treatment with CTLA4-Ig (Abatacept)

Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis

COVID-19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration.

Lymphadenopathy in IgG4-related disease: a phenotype of severe activity and poor prognosis, with eotaxin-3 as a new biomarker.

Milk fat globule epidermal growth factor 8 (MFG-E8) on monocytes is a novel biomarker of disease activity in systemic lupus erythematosus.

Collaborators (3)

Yuko Kaneko

Kathryn A. Gibson

Fumio Hirano

Make your next move.